Dry Eye Disease

It is likely that one or more “promising treatments” currently being investigated for Sjögren’s syndrome will come into use within the next 3 to 5 years, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

AR-15512 achieved statistical significance for multiple sign and symptom endpoints in patients with dry eye disease, according to a press release from Aerie Pharmaceuticals.

As I amble across the dry eye disease landscape, I come across all manner of things that are just not quite ready for prime time.

Stuart Therapeutics has completed patient enrollment in a phase 2 clinical trial of ST-100 for the treatment of dry eye disease.

EyeGate Pharmaceuticals has completed enrollment in a phase 2 proof-of-concept study investigating PP-001 in patients with ocular surface inflammation, according to a press release.

Maximizing vision for our patients goes well beyond getting them to a visual acuity of 20/20.

AXR-270 demonstrated "statistically and clinically meaningful improvement" in patients with dry eye disease associated with meibomian gland dysfunction, according to a press release from AxeroVision.

Phase 3 study results of a presbyopia drop and discussions about dry eye disease treatments topped videos from the American Society of Cataract and Refractive Surgery meeting held in Las Vegas earlier this summer.

Fluctuating dry eye symptoms following surgery or exposure to environmental triggers are “highly suggestive” of flares, according to a poster presented at the Women in Ophthalmology Summer Symposium.

Ladies and gentlemen, we have ourselves a contest here!